Eric Schordan

869 total citations
19 papers, 482 citations indexed

About

Eric Schordan is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Eric Schordan has authored 19 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Nephrology. Recurrent topics in Eric Schordan's work include Renal Diseases and Glomerulopathies (4 papers), Bone health and treatments (3 papers) and MicroRNA in disease regulation (3 papers). Eric Schordan is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Bone health and treatments (3 papers) and MicroRNA in disease regulation (3 papers). Eric Schordan collaborates with scholars based in France, Germany and Switzerland. Eric Schordan's co-authors include Karlhans Endlich, Sylvie Rothhut, Jean‐Jacques Helwig, Nicole Endlich, Thierry Massfelder, Véronique Lindner, Hervé Lang, Didier Jacqmin, Sandra Schordan and Carole Sourbier and has published in prestigious journals such as Cancer Research, Scientific Reports and Endocrinology.

In The Last Decade

Eric Schordan

19 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Schordan France 12 294 119 108 107 86 19 482
José M. Muñoz‐Félix Spain 14 293 1.0× 67 0.6× 109 1.0× 86 0.8× 91 1.1× 26 527
Xiwu Chen United States 11 223 0.8× 107 0.9× 77 0.7× 75 0.7× 40 0.5× 13 486
Alessio Iannetti Italy 6 344 1.2× 266 2.2× 64 0.6× 115 1.1× 61 0.7× 6 595
Anna Berg Norway 16 287 1.0× 150 1.3× 58 0.5× 167 1.6× 103 1.2× 21 683
Lucie Coppin France 14 177 0.6× 70 0.6× 55 0.5× 140 1.3× 53 0.6× 25 421
Wei‐Hwa Lee Taiwan 11 209 0.7× 86 0.7× 31 0.3× 123 1.1× 86 1.0× 26 464
Stefan Amatschek Austria 9 297 1.0× 93 0.8× 31 0.3× 185 1.7× 60 0.7× 9 567
Shirley L. Cortez United States 10 200 0.7× 223 1.9× 161 1.5× 61 0.6× 49 0.6× 11 575
Tian Ding China 9 215 0.7× 97 0.8× 39 0.4× 118 1.1× 57 0.7× 19 502
Robert Doiron United States 5 167 0.6× 72 0.6× 60 0.6× 73 0.7× 48 0.6× 6 376

Countries citing papers authored by Eric Schordan

Since Specialization
Citations

This map shows the geographic impact of Eric Schordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Schordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Schordan more than expected).

Fields of papers citing papers by Eric Schordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Schordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Schordan. The network helps show where Eric Schordan may publish in the future.

Co-authorship network of co-authors of Eric Schordan

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Schordan. A scholar is included among the top collaborators of Eric Schordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Schordan. Eric Schordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Firat, Hüseyin, Lu Zhang, Shounak Baksi, et al.. (2023). FIMICS: A panel of long noncoding RNAs for cardiovascular conditions. Heliyon. 9(1). e13087–e13087. 8 indexed citations
2.
Greco, Simona, Mélanie Vausort, Eric Schordan, et al.. (2022). Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality. Scientific Reports. 12(1). 20048–20048. 11 indexed citations
3.
Kong, Xiang Yi, Dan Atar, David Russell, et al.. (2020). Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study. Cerebrovascular Diseases Extra. 10(1). 11–20. 7 indexed citations
4.
Firat, Hüseyin, Frédéric Blanc, Sabrina Danilin, et al.. (2020). lncRNAs as a novel source of diagnostic applications for early Alzheimer’s disease and other dementia types. Alzheimer s & Dementia. 16(S4). 2 indexed citations
5.
Duroux-Richard, Isabelle, et al.. (2019). MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?. Frontiers in Immunology. 10. 375–375. 45 indexed citations
6.
Jeziorski, Éric, Marion Delpont, Maïlys Cren, et al.. (2019). Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis. Cells. 8(12). 1521–1521. 16 indexed citations
7.
Schordan, Eric, Hüseyin Firat, Nadir Arber, et al.. (2018). FRI0675 Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 77. 857–858. 1 indexed citations
8.
Schordan, Eric, et al.. (2016). THU0131 Mirna Profiling Using HTG-Edgeseq Platform Predicts Response To anti-TNF Alpha Therapy in Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 75. 228–228. 1 indexed citations
9.
Blumenthal, Antje, Gregor Warsow, Ramesh Ummanni, et al.. (2014). Mechanical stress enhances CD9 expression in cultured podocytes. American Journal of Physiology-Renal Physiology. 308(6). F602–F613. 9 indexed citations
10.
Warsow, Gregor, Nicole Endlich, Eric Schordan, et al.. (2013). PodNet, a protein–protein interaction network of the podocyte. Kidney International. 84(1). 104–115. 18 indexed citations
11.
Schordan, Sandra, Olaf Grisk, Eric Schordan, et al.. (2013). OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice. American Journal of Physiology-Renal Physiology. 304(12). F1458–F1470. 17 indexed citations
12.
Schordan, Sandra, Eric Schordan, Karlhans Endlich, & Nicole Endlich. (2010). αV-Integrins mediate the mechanoprotective action of osteopontin in podocytes. American Journal of Physiology-Renal Physiology. 300(1). F119–F132. 44 indexed citations
13.
Schordan, Sandra, Eric Schordan, Nicole Endlich, et al.. (2009). Alterations of the podocyte proteome in response to high glucose concentrations. PROTEOMICS. 9(19). 4519–4528. 28 indexed citations
14.
Endlich, Nicole, Eric Schordan, Clemens D. Cohen, et al.. (2008). Palladin is a dynamic actin-associated protein in podocytes. Kidney International. 75(2). 214–226. 44 indexed citations
15.
Schordan, Eric, Catherine Coquard, Thierry Massfelder, et al.. (2006). Abnormal Renovascular Parathyroid Hormone-1 Receptor in Hypertension: Primary Defect or Secondary to Angiotensin II Type 1 Receptor Activation?. Endocrinology. 147(9). 4384–4391. 3 indexed citations
16.
Sourbier, Carole, Véronique Lindner, Hervé Lang, et al.. (2006). The Phosphoinositide 3-Kinase/Akt Pathway: A New Target in Human Renal Cell Carcinoma Therapy. Cancer Research. 66(10). 5130–5142. 130 indexed citations
17.
Talon, Isabelle, Véronique Lindner, Carole Sourbier, et al.. (2005). Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis. 27(1). 73–83. 29 indexed citations
18.
Schordan, Eric, et al.. (2004). Role of Parathyroid Hormone–Related Protein in the Regulation of Stretch-Induced Renal Vascular Smooth Muscle Cell Proliferation. Journal of the American Society of Nephrology. 15(12). 3016–3025. 13 indexed citations
19.
Massfelder, Thierry, Hervé Lang, Eric Schordan, et al.. (2004). Parathyroid Hormone-Related Protein Is an Essential Growth Factor for Human Clear Cell Renal Carcinoma and a Target for the von Hippel-Lindau Tumor Suppressor Gene. Cancer Research. 64(1). 180–188. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José M. Muñoz‐Félix Breakdown of academic impact, for papers by Xiwu Chen Breakdown of academic impact, for papers by Alessio Iannetti Breakdown of academic impact, for papers by Anna Berg Breakdown of academic impact, for papers by Lucie Coppin Breakdown of academic impact, for papers by Wei‐Hwa Lee Breakdown of academic impact, for papers by Stefan Amatschek Breakdown of academic impact, for papers by Shirley L. Cortez Breakdown of academic impact, for papers by Tian Ding Breakdown of academic impact, for papers by Robert Doiron
Rankless by CCL
2026